Skip to main content
. 2016 Jun 2;7(1):106–115. doi: 10.1016/j.apsb.2016.05.002

Figure 4.

Fig. 4

(A) Mitochondrial morphology of L02 cells and HepG2 cells treated with MitoCaA or MitoCaA+CsA (0.4 μmol/L) for 4 h. The mitochondrial network and morphology were visualized using MitoTracker Green FM staining and a confocal microscope. (B) Flow cytometry analyses for the apoptotic induction of HepG2 cells after 24 h treatment with MitoCaA or MitoCaA+CsA (0.4 μmol/L). (C) Cell viability of HepG2 cells after 24 h treatment with MitoCaA or MitoCaA+CsA. The values represent mean±SEM of three independent experiments.